ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,176Medicare Part D Prescriptions Filled, Including Refills

Rank: 781 out of 2888

$819K Total Retail Price of All Prescriptions

Rank: 340 out of 2888

620 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 620 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 6,671 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$100 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
CRESTOR 298 246 1 20
NEXIUM 257 212 2 19
TRAMADOL HCL-ACETAMINOPHEN 250 187 3 95
AMLODIPINE BESYLATE 232 206 4 5
METOPROLOL SUCCINATE 209 173 5 11
CEPHALEXIN 182 131 6 119
LEVOTHYROXINE SODIUM 178 148 7 1
CLOPIDOGREL 170 145 8 30
METFORMIN HCL 147 108 9 8
LISINOPRIL 145 127 10 3
JANUVIA 144 121 11 48
CALCITRIOL 142 122 12 222
OMEPRAZOLE 140 104 13 7
ALENDRONATE SODIUM 139 129 14 23
FUROSEMIDE 138 118 15 6
PRAVASTATIN SODIUM 133 106 16 12
SULFAMETHOXAZOLE-TRIMETHOPRIM 132 107 17 88
LISINOPRIL-HYDROCHLOROTHIAZIDE 130 110 18 28
LOSARTAN POTASSIUM 117 85 19 18
METOPROLOL TARTRATE 115 87 20 10
CLONIDINE HCL 114 99 21 39
VOLTAREN 109 90 22 157
LOSARTAN-HYDROCHLOROTHIAZIDE 105 90 23 46
PLAVIX 99 78 24 40
SIMVASTATIN 98 78 25 2
JANUMET 90 60 26 131
LOVASTATIN 88 64 27 41
PRANDIN 86 86 28 305
CIPROFLOXACIN HCL 85 70 29 47
WARFARIN SODIUM 81 70 30 22
CARVEDILOL 78 72 31 21
ZOLPIDEM TARTRATE 76 71 32 17
TRAMADOL HCL 75 58 33 16
POLYETHYLENE GLYCOL 3350 72 58 34 93
LANTUS 71 66 35 45
IBUPROFEN 67 48 36 87
DIOVAN HCT 66 63 37 61
ATORVASTATIN CALCIUM 64 56 38 9
RANITIDINE HCL 62 43 39 56
LANTUS SOLOSTAR 62 42 39 92
ESCITALOPRAM OXALATE 58 42 41 62
HYDROCHLOROTHIAZIDE 56 49 42 15
GLIPIZIDE 53 39 43 50
LIDODERM 52 33 44 105
CLOTRIMAZOLE 51 39 45 294
AMMONIUM LACTATE 51 36 45 360
CYMBALTA 51 44 45 44
GLYBURIDE-METFORMIN HCL 50 41 R 48 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.